UBS Group’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-95,104
| Closed | -$981K | – | 10466 |
|
|
2023
Q3 | $981K | Buy |
95,104
+94,599
| +18,732% | +$898K | ﹤0.01% | 4090 |
|
|
2023
Q2 | $4.17K | Sell |
505
-1,298,997
| -100% | -$7.77M | ﹤0.01% | 7560 |
|
|
2023
Q1 | $7.26M | Sell |
1,299,502
-3,074
| -0.2% | -$17.6K | ﹤0.01% | 2166 |
|
|
2022
Q4 | $6.45M | Buy |
1,302,576
+924,421
| +244% | +$3.81M | ﹤0.01% | 2253 |
|
|
2022
Q3 | $1.81M | Buy |
378,155
+374,761
| +11,042% | +$1.61M | ﹤0.01% | 3247 |
|
|
2022
Q2 | $8K | Buy |
3,394
+2,833
| +505% | +$10.6K | ﹤0.01% | 8401 |
|
|
2022
Q1 | $3K | Sell |
561
-25,748
| -98% | -$231K | ﹤0.01% | 9532 |
|
|
2021
Q4 | $394K | Sell |
26,309
-2,888
| -10% | -$52.6K | ﹤0.01% | 5177 |
|
|
2021
Q3 | $765K | Buy |
29,197
+3,061
| +12% | +$113K | ﹤0.01% | 4406 |
|
|
2021
Q2 | $1.31M | Sell |
26,136
-13,175
| -34% | -$590K | ﹤0.01% | 3950 |
|
|
2021
Q1 | $1.81M | Sell |
39,311
-3,539
| -8% | -$169K | ﹤0.01% | 3656 |
|
|
2020
Q4 | $1.84M | Buy |
42,850
+378
| +0.9% | +$14.3K | ﹤0.01% | 3473 |
|
|
2020
Q3 | $1.73M | Buy |
42,472
+35,816
| +538% | +$1.78M | ﹤0.01% | 3184 |
|
|
2020
Q2 | $365K | Sell |
6,656
-8,741
| -57% | -$500K | ﹤0.01% | 4378 |
|
|
2020
Q1 | $805K | Sell |
15,397
-2,404
| -14% | -$130K | ﹤0.01% | 3545 |
|
|
2019
Q4 | $867K | Sell |
17,801
-3,148
| -15% | -$147K | ﹤0.01% | 4342 |
|
|
2019
Q3 | $1.15M | Buy |
20,949
+15,425
| +279% | +$883K | ﹤0.01% | 3840 |
|
|
2019
Q2 | $275K | Buy |
5,524
+4,684
| +558% | +$233K | ﹤0.01% | 4706 |
|
|
2019
Q1 | $47K | Sell |
840
-16,550
| -95% | -$986K | ﹤0.01% | 5593 |
|
|
2018
Q4 | $1.11M | Sell |
17,390
-4,708
| -21% | -$333K | ﹤0.01% | 3583 |
|
|
2018
Q3 | $1.79M | Buy |
22,098
+2,963
| +15% | +$217K | ﹤0.01% | 3314 |
|
|
2018
Q2 | $1.22M | Sell |
19,135
-13,541
| -41% | -$664K | ﹤0.01% | 3602 |
|
|
2018
Q1 | $1.27M | Buy |
32,676
+30,503
| +1,404% | +$1.07M | ﹤0.01% | 3532 |
|
|
2017
Q4 | $61K | Buy |
2,173
+1,588
| +271% | +$46.5K | ﹤0.01% | 5696 |
|
|
2017
Q3 | $16K | Buy |
585
+470
| +409% | +$8.97K | ﹤0.01% | 6616 |
|
|
2017
Q2 | $2K | Sell |
115
-1,546
| -93% | -$20.9K | ﹤0.01% | 7414 |
|
|
2017
Q1 | $22K | Sell |
1,661
-10,312
| -86% | -$148K | ﹤0.01% | 6079 |
|
|
2016
Q4 | $179K | Buy |
+11,973
| New | +$153K | ﹤0.01% | 4879 |
|
Other funds holding TRHC
UBS Group's TRHC Position: Q4 2023 in Review
UBS Group sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 95,104 shares — an estimated $981K sold.
UBS Group first reported a position in TRHC in Q4 2016 and held it in 28 quarters. The position peaked at $7.26M in Q1 2023. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- UBS Group reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 95,104 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $981K.
- UBS Group first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 28 quarters.
- UBS Group's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $7.26M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.